This article was originally published on PharmaTimes http://www.pharmatimes.com/news/norgine_launches_shields_feraccru_in_the_uk_1272047

Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.

Related Posts